Interactions between alcohol and the HIV entry inhibitor Maraviroc.
J Int Assoc Provid AIDS Care
; 12(6): 375-7, 2013.
Article
en En
| MEDLINE
| ID: mdl-23881910
ABSTRACT
BACKGROUND:
Alcohol use is common among people with HIV, and beliefs about alcohol interactions with medications predict decreased medication adherence, risking drug-resistant mutations. Maraviroc is an HIV entry inhibitor approved for treatment of both drug-sensitive and drug-resistant HIV strains. The present study evaluated the effects of alcohol on maraviroc pharmacokinetics and the effects of maraviroc on alcohol pharmacokinetics.METHODS:
Ten healthy adults completed alcohol (1 g/kg) and placebo alcohol pharmacokinetics sessions before and after 7 days of maraviroc administration.RESULTS:
Alcohol concentrations increased 12% following maraviroc. Maraviroc pharmacokinetics were unaffected by alcohol.CONCLUSIONS:
Maraviroc treatment should not be interrupted if alcohol is consumed.Palabras clave
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Triazoles
/
Consumo de Bebidas Alcohólicas
/
Infecciones por VIH
/
Ciclohexanos
/
Inhibidores de Fusión de VIH
/
Etanol
Tipo de estudio:
Clinical_trials
/
Prognostic_studies
Límite:
Adult
/
Female
/
Humans
/
Male
Idioma:
En
Revista:
J Int Assoc Provid AIDS Care
Año:
2013
Tipo del documento:
Article
País de afiliación:
Estados Unidos